Skip to main content

III.G. Vitreous in Age-Related Macular Degeneration

  • Chapter
  • First Online:
Vitreous

Abstract

Due to the increasing importance of age-related macular degeneration (AMD) in the modern western world an enormous number of scientific papers have been published concerning the epidemiology, pathogenesis, morphology, and therapy of this disease. All these articles mainly concentrated on changes of the posterior part of the retina, as AMD is a disease of the chorioretinal interface, specifically the retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. In the past, only a few studies examined the relationship of the posterior vitreous cortex and the retina and changes at the vitreo-macular interface in eyes suffering from AMD. Weber-Krause et al. conducted a study based on B-scan ultrasound and reported a higher incidence of incomplete posterior vitreous detachment (PVD) in eyes with AMD compared to age-matched controls [1]. Similarly, Ondes et al. found that complete PVD was more frequent in eyes without AMD compared to eyes with AMD [2]. Neither study specifically evaluated the vitreo-macular relationship in AMD, although it was implicit that anomalous PVD may play a role, as it does in other conditions [see chapter III.B. Anomalous PVD and vitreoschisis].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weber-Krause B, Eckardt C. Incidence of posterior vitreous detachment in the elderly. Ophthalmologe. 1997;94:619–23. German.

    Article  PubMed  CAS  Google Scholar 

  2. Ondes F, Yilmaz G, Acar MA, Unlu N, Kocaoglan H, Arsan AK. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol. 2000;44(1):91–3.

    Article  PubMed  CAS  Google Scholar 

  3. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45:4151–60.

    Article  PubMed  Google Scholar 

  4. Foos RY. Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:480–97.

    PubMed  CAS  Google Scholar 

  5. Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007;144(5):741–6. Epub 2007 Sep 20.

    Article  PubMed  Google Scholar 

  6. Robison CD, Krebs I, Binder S, Barbazetto IA, Kotsolis AI, Yannuzzi LA, Sadun AA, Sebag J. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol. 2009;148:79–82.

    Article  PubMed  Google Scholar 

  7. Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol. 2009;147:621–6.

    Article  PubMed  Google Scholar 

  8. Krebs I, Glittenberg C, Zeiler F, Binder S. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration. Br J Ophthalmol. 2011;95(10):1415–8.

    Article  PubMed  Google Scholar 

  9. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.

    Article  PubMed  CAS  Google Scholar 

  10. Slakter JS, Yannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2000;107:742–53.

    Article  PubMed  CAS  Google Scholar 

  11. Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, Matsumoto Y, Sorenson JA, Yannuzzi L. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008;28:201–11.

    Article  PubMed  Google Scholar 

  12. Mojana F, Cheng L, Bartsch DU, Silva GA, Kozak I, Nigam N, Freeman WR. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008;146:218–27.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang MY, Nguyen D, Hindoyan N, Sadun AA, Sebag J. Vitreo-papillary adhesion in macular hole and macular pucker. Retina. 2009;29:644–50.

    Article  PubMed  Google Scholar 

  14. Sebag J, Wang MY, Nguyen D, Sadun AA. Vitreopapillary adhesion in macular diseases. Trans Am Ophthalmol Soc. 2009;107:35–44.

    PubMed  CAS  PubMed Central  Google Scholar 

  15. Gupta P, Yee KM, Garcia P, Rosen RB, Parikh J, Hageman GS, Sadun AA, Sebag J. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011;95(3):376–80. doi:10.1136/bjo.2009.175109. Epub 2010 Jun 28.

    Article  PubMed  Google Scholar 

  16. Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol. 2008;246(3):329–32. doi:10.1007/s00417-007-0743-x. Epub 2008 Jan 29.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC, Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484–98.

    Article  PubMed  Google Scholar 

  18. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R, Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570–4.

    Article  PubMed  Google Scholar 

  19. Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U. Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study. Retina. 2012;32(3):424–33.

    Article  PubMed  Google Scholar 

  20. Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H. Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol. 2013;251(7):1691–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364(20):1897–908. Epub 2011 Apr 28.

    Article  Google Scholar 

  22. IVAN Study Investigators, Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012;119(7):1399–411. Epub 2012 May 11.

    Article  Google Scholar 

  23. Krebs I, Schmetterer L, Boltz A, Told R, Vécsei-Marlovits V, Egger S, Schönherr U, Haas A, Ansari-Shahrezaei S, Binder S; for the MANTA Research Group. A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol. 2013. 97(3):266-71.

    Google Scholar 

  24. Krebs I, Glittenberg C, Ansari-Shahrezaei S, Hagen S, Steiner I, Binder S. Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration. Br J Ophthalmol. 2013;97(11):1443–6. doi:10.1136/bjophthalmol-2013-303513. Epub 2013 Aug 21.

    Article  PubMed  Google Scholar 

  25. Lee SJ, Koh HJ. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology. 2011;118(1):101–10.

    Article  PubMed  Google Scholar 

  26. Schulze S, Hoerle S, Mennel S, Kroll P. Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol. 2008;86(5):470–81. doi:10.1111/j.1755-3768.2008.01210.x. Epub 2008 Jun 28. Review.

    Article  PubMed  Google Scholar 

  27. Simpson AR, Petrarca R, Jackson TL. Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol. 2012;57(6):498–509. doi:10.1016/j.survophthal.2012.01.011.

    Article  PubMed  Google Scholar 

  28. Cho M, Barbazetto IA, Freund KB. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol. 2009;148(1):70–8.

    Article  PubMed  Google Scholar 

  29. Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina. 2012;32(6):1181–9. doi:10.1097/IAE.0b013e318235d8ce.

    Article  PubMed  CAS  Google Scholar 

  30. Nomura Y, Ueta T, Iriyama A, Inoue Y, Obata R, Tamaki Y, Yamaguchi T, Yanagi Y. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology. 2011;118(5):853–9. doi:10.1016/j.ophtha.2010.09.001. Epub 2010 Nov 20.

    Article  PubMed  Google Scholar 

  31. Roller AB, Mahajan VB, Boldt HC, Abramoff MD, Russell SR, Folk JC. Effects of vitrectomy on age-related macular degeneration. Ophthalmology. 2010;117(7):1381–6. doi:10.1016/j.ophtha.2009.11.007. Epub 2010 Feb 21.

    Article  PubMed  Google Scholar 

  32. Schulze S, Neugebauer A, Kroll P. Appearance of age-related macular degeneration in vitrectomized and nonvitrectomized eyes: an intraindividual case study. Acta Ophthalmol. 2012;90(3):244–7. doi:10.1111/j.1755-3768.2010.01929.x. Epub 2010 May 14.

    Article  PubMed  Google Scholar 

  33. Ikeda T, Sawa H, Koizumi K, Yasuhara T, Yamasaki T. Pars plana vitrectomy for regression of choroidal neovascularization with age-related macular degeneration. Acta Ophthalmol Scand. 2000;78(4):460–4.

    Article  PubMed  CAS  Google Scholar 

  34. Sakamoto T, Sheu SJ, Arimura N, Sameshima S, Shimura M, Uemura A, Kawano H, Wu TT, Kubota T, Sohma R, Noda Y. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage. Retina. 2010;30(6):856–64. doi:10.1097/IAE.0b013e3181c969cb.

    Article  PubMed  Google Scholar 

  35. Shah SU, Haller JA. Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy. Acta Ophthalmol. 2012;90(7):e569–70. doi:10.1111/j.1755-3768.2011.02372.x. Epub 2012 Mar 16.

    Article  PubMed  Google Scholar 

  36. Schmidt JC, Mennel S, Hörle S, Meyer CH. High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy. Br J Ophthalmol. 2006;90(11):1361–2. Epub 2006 Jul 19.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  37. Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1019–23. doi:10.1007/s00417-009-1072-z. Epub 2009 Apr 4.

    Article  PubMed  Google Scholar 

  38. Maeda N, Tano Y. Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous. Graefes Arch Clin Exp Ophthalmol. 1996;234 Suppl 1:S66–9.

    Article  PubMed  Google Scholar 

  39. Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):147–63. doi:10.1007/s00417-008-0980-7. Epub 2008 Nov 26. Review.

    Article  PubMed  Google Scholar 

  40. Sebag J. Pharmacologic vitreolysis (Guest Editorial). Retina 1998;18:1–3.

    Article  PubMed  CAS  Google Scholar 

  41. Sebag J. Pharmacologic vitreolysis - premise and promise of the first decade. Retina. 2009;29(7):871–4. doi:10.1097/IAE.0b013e3181ac7b3c.

    Article  PubMed  CAS  Google Scholar 

  42. Kim YM, Lee SJ, Koh HJ. Gas-assisted release of vitreomacular adhesion in wet age-related macular degeneration. Retina. 2011;31(10):2123–4.

    PubMed  Google Scholar 

  43. Abrishami M, Moosavi MN, Shoeibi N, Hosseinpoor SS. Intravitreal tissue plasminogen activator to treat refractory diabetic macular edema by induction of posterior vitreous detachment. Retina. 2011;31(10):2065–70.

    Article  PubMed  CAS  Google Scholar 

  44. Kuppermann BD. Ocriplasmin for pharmacologic vitreolysis. Retina. 2012;32 Suppl 2:S225–8; discussion S228-31.

    Article  PubMed  CAS  Google Scholar 

  45. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration–what is the cause? Retina. 2003;23:595–614.

    Article  PubMed  Google Scholar 

  46. Grossniklaus HE, Miskala PH, Green WR, Bressler SB, Hawkins BS, Toth C, Wilson DJ, Bressler NM. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol. 2005;123(7):914–21.

    Article  PubMed  Google Scholar 

  47. Stefánsson E, Geirsdóttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res. 2011;30(1):72–80. doi:10.1016/j.preteyeres.2010.09.003. Epub 2010 Oct 15.

    Article  PubMed  Google Scholar 

  48. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51(2):137–52. Review.

    Article  PubMed  Google Scholar 

  49. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27(8):1090–6.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37(9):1929–34.

    PubMed  CAS  Google Scholar 

  51. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005;25(2):111–8. Review.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanne Binder MD .

Editor information

Editors and Affiliations

Electronic Supplementary Material

Video III.G-1

VMT with CNV (virtual C-mode and RPE-fit slab). This video shows how to visualize the correlation between VMT and a CNV located immediately beneath it using the RPE-fit slab capability of the Carl Zeissâ„¢ Cirrus HD-OCT. By creating a virtual C-mode visualization, whose contour can be adjusted to fit the contour of the RPE, it is possible to show the exact location of the CNV and its relationship to the forces of vitreo-macular traction and adhesion immediately above it (AVI 131278 kb)

Video III.G-2

VMT with no CNV (virtual C-mode and RPE-fit slab). This video shows the same method as described in Video III.G-1 used on a patient with VMT and no CNV for the sake of comparison. The same process of scrolling through the RPE-fit virtual C-mode scan reveals no CNV relating to the area of the VMT (AVI 131278 kb)

Video III.G-3

VMT with CNV (real-time interactive voxel rendering). This video shows a real-time screen-grab of the voxel rendering system in use. The system is based on a plug-in that was written for the 3D rendering and animation program Maxonâ„¢ Cinema 4Dâ„¢. This system has the capability of creating real-time visualizations of segmentational data sets. It differs fundamentally from conventional visualization systems in as much as it creates ray-traced shading directly on the data set interactively. This capability greatly increases the detail and quality of the visualization (AVI 131278 kb)

Video III.G-4

VMT with CNV (voxel rendering). This video shows the same case as in Videos III.G-1 and III.G-3 visualized using a prerendered voxel visualization as described in Video III.G-3. The white arrow shows the location of the CNV under the VMT and adhesion. As can be seen in the visualization, the direction of the folds in the VMT points at the location of the CNV indicating a correlation between tractional forces and the presence of CNV (AVI 131278 kb)

Video III.G-5

VMT with CNV (real-time interactive GPU rendering). This video shows the same case as in Videos III.G-1, III.G-3, and III.G-4 visualized using a GPU-based triangle-mesh segmentation visualization system designed using CUDA algorithms and rendered on an Nvidea GTX GeForce 590 graphics card. This video shows a screen-grab of the interactive real-time capabilities of the system. The black lines show the correlation between the tractional forces of the VMT and the location of the CNV (AVI 131278 kb)

Video III.G-6

VMT with CNV (GPU rendering). This video shows the same case as in Videos III.G-1, III.G-3, III.G-4, and III.G-5 using the same visualization system described in Video III.G-5. This video is a prerendered animation (non-real time) showing the correlation between the VMT and the location of the CNV (black lines) (AVI 131278 kb)

Video III.G-7

VMT with no CNV (GPU rendering). This video shows the same case as in Video III.G-2 using the visualization system described in Videos III.G-5 and III.G-6. In this case, there is VMT and MP but no underlying CNV. (AVI 131278 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Krebs, I., Glittenberg, C., Binder, S. (2014). III.G. Vitreous in Age-Related Macular Degeneration. In: Sebag, J. (eds) Vitreous. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1086-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1086-1_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1085-4

  • Online ISBN: 978-1-4939-1086-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics